Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 10.24 Delayed Data As of Jun 09 |  -0.13 / -1.25%Today’s Change | 4.82 Today|||52-Week Range 11.12 | +39.32% Year-to-Date |
Latest ALPN News | Press Releases
No recent news for Alpine Immune Sciences Inc.
Today’s Trading
| Previous close | 10.37 |
| Today’s open | 10.61 |
| Day’s range | 10.22 - 10.61 |
| Volume | 1,993 |
| Average volume (3 months) | 103,068 |
| Market cap | $506.0M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +12.55% |
| Earnings growth (this year) | +17.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +28.24% |
| P/E ratio | NM |
| Price/Sales | 8.17 |
| Price/Book | 2.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUTLAutolus Therapeutics... | -0.05 | -1.71% |
| CHRSCoherus BioSciences ... | +0.04 | +0.74% |
| ANABAnaptysBio Inc | +0.42 | +2.29% |
| ---- |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $30.1M |
| Annual profit (last year) | -$57.8M |
| Net profit margin | -192.13% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
